These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4128775)

  • 41. [Immunotherapy of leukemia].
    Amiel JL
    Brux Med; 1970 Mar; 50(3):185-94. PubMed ID: 5267258
    [No Abstract]   [Full Text] [Related]  

  • 42. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 43. Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin.
    Vogler WR; Chan YK
    Lancet; 1974 Jul; 2(7873):128-31. PubMed ID: 4135502
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.
    Gutterman JU; Hersh EM; Rodriguez V; McCredie KB; Mavligit G; Reed R; Burgess MA; Smith T; Gehan E; Bodey GP; Freireich EJ
    Lancet; 1974 Dec; 2(7894):1405-9. PubMed ID: 4140327
    [No Abstract]   [Full Text] [Related]  

  • 45. [Trials of active immunotherapy in acute lymphocytic leukemia. Influence of different factors on results. Study of 100 cases].
    Mathé G; Pouillart P; Schwarzenberg L; Weiner R; Hayat M; Amiel JL; Rosenfeld C; Schneider M; Cattan A; de Vassal F
    Nouv Presse Med; 1973 Mar; 2(9):557-62. PubMed ID: 4512967
    [No Abstract]   [Full Text] [Related]  

  • 46. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination of chemotherapy, radiotherapy and immunotherapy for acute lymphoblastic leukemia in children.
    Suvatte V; Mahasandana C; Tanphaichitr VS; Tuchinda S; Vootiprux V
    J Med Assoc Thai; 1981 Apr; 64(4):180-91. PubMed ID: 6942080
    [No Abstract]   [Full Text] [Related]  

  • 48. Cancer immunotherapy.
    Eagan RT; Sparks FC; Morton DL
    Ann Intern Med; 1973 Jan; 78(1):153-4. PubMed ID: 4509124
    [No Abstract]   [Full Text] [Related]  

  • 49. [Demonstration of the efficacy of active immunotherapy in human acute lymphoblastic leukemia].
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Hayat M; de Vassal F
    Rev Fr Etud Clin Biol; 1968 May; 13(5):454-9. PubMed ID: 5244759
    [No Abstract]   [Full Text] [Related]  

  • 50. Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
    Pearson JW; Chirigos MA; Chaparas SD; Sher NA
    J Natl Cancer Inst; 1974 Feb; 52(2):463-8. PubMed ID: 4593139
    [No Abstract]   [Full Text] [Related]  

  • 51. Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.
    Joseph RR; Belpomme D; Mathé G
    Br J Cancer; 1976 May; 33(5):567-70. PubMed ID: 776199
    [No Abstract]   [Full Text] [Related]  

  • 52. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 53. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
    Miale TD; Yocum D; Yocum C
    Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia.
    Ohino R; Ueda R; Imai Kato Y; Watanabe E; Morishima Y; Yokomaku S; Kobayashi M; Takeyama H; Ezaki K; Kawashima K; Hirano M; Ohara K; Kosaki T; Yoshikawa S; Yamada K
    Gan; 1978 Apr; 69(2):179-86. PubMed ID: 355038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunology and immunotherapy of leukemia (basic results of 8-years research)].
    Bergol'ts VM
    Vopr Onkol; 1978; 24(11):16-24. PubMed ID: 283626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter: Routes other than I.V. injection to mice for BCG administration in active immunotherapy of L1210 leukemia.
    Martin M; Bourut C; Halle-Pannenko O; Mathé
    Biomedicine; 1975 Oct; 23(8):339-40. PubMed ID: 1231929
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inhibition of neoplasms by stimulation of immunity. Experimental aspects (with review of the questions discussed)].
    Lemonde P
    Union Med Can; 1974 Oct; 103(10):1716-28. PubMed ID: 4378396
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of intravenous B.C.G. in guineapigs and pertinence to cancer immunotherapy in man.
    Muggleton PW; Prince GH; Hilton ML
    Lancet; 1975 Jun; 1(7921):1353-5. PubMed ID: 48944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-up of the first (1962) pilot study of active immunotherapy of acute lymphoid leukaemia: a critical discussion.
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Hayat M; De Vassal F
    Biomedicine; 1977 Feb; 26(1):29-35. PubMed ID: 266407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.